title: In vitro treatment of bone marrow from patients with T-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma using the immunotoxin WT1-ricin A.
authors.affiliation: ICRF Department of Medical Oncology, St. Bartholomew's Hospital, London, UK.
authors.forename: M J
authors.initials: MJ
authors.lastname: Barnett
authors.forename: A Z
authors.initials: AZ
authors.lastname: Rohatiner
authors.forename: J E
authors.initials: JE
authors.lastname: Kingston
authors.forename: K E
authors.initials: KE
authors.lastname: Adams
authors.forename: E L
authors.initials: EL
authors.lastname: Batten
authors.forename: R
authors.initials: R
authors.lastname: Bassan
authors.forename: P E
authors.initials: PE
authors.lastname: Thorpe
authors.forename: M A
authors.initials: MA
authors.lastname: Horton
authors.forename: J S
authors.initials: JS
authors.lastname: Malpas
authors.forename: T A
authors.initials: TA
authors.lastname: Lister
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects*; D016026:Bone Marrow Transplantation; D002648:Child; D005260:Female; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D066298:In Vitro Techniques; D007945:Leukemia, Lymphoid / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012276:Ricin / Q000627:therapeutic use*; D014182:Transplantation, Autologous
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D012276:Ricin